Maharashtra FDA Seeks Price Controls for Essential Medical Devices

The record

Written from the 1 report below. Nothing here is unsourced.

The Maharashtra Food and Drug Administration has asked the central government to bring essential medical devices under price control.
The state agency found that hospitals pay far less to procure many medical devices than the maximum retail prices declared for them.
The agency specifically flagged devices used during inpatient treatment as needing greater transparency and oversight.
The regulator has asked the central government to examine these pricing discrepancies between procurement cost and declared retail price.
The gap between what hospitals pay and what patients are charged points to higher healthcare expenses for patients under the current regulatory setup.

Whether the central government responds to Maharashtra FDA's request and initiates a review of medical device pricing.
Whether price regulation is extended to devices used in inpatient treatment.
Any disclosure or tightening of rules on the gap between procurement cost and declared maximum retail price.

Grouped by subject or cast while the story boundary is under human review. No chronology is implied.

Loading the story…

1 report

English national1

All filed from India

Named India · Food and Drug Administration of Maharashtra · Government of India

The 1 report is listed beside the record.

Answers cite the reports above, or say they can't.